Patents by Inventor Michael C. Giddings

Michael C. Giddings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8202982
    Abstract: Methods for obtaining antisense oligonucleotides with activity against a desired target are provided. Methods of identifying oligonucleotide sequence motifs which are predictive of antisense oligonucleotide activity are provided, as are motifs identified according to this method. Methods of selecting effective antisense oligonucleotide sequences and effective antisense target sequences are provided, as are sequences selected according to these methods. In other methods of the invention, oligonucleotides are designed to hybridize to target sequences containing one or more activity-enhancing motifs. Antisense oligonucleotides designed according to these methods are also provided.
    Type: Grant
    Filed: September 10, 2009
    Date of Patent: June 19, 2012
    Assignee: Isis Phramaceuticals, Inc.
    Inventors: Susan M. Freier, Olga Matveeva, Alexander Tsodikov, Michael C. Giddings, Jacqueline R. Wyatt
  • Publication number: 20100113292
    Abstract: Methods for obtaining antisense oligonucleotides with activity against a desired target are provided. Methods of identifying oligonucleotide sequence motifs which are predictive of antisense oligonucleotide activity are provided, as are motifs identified according to this method. Methods of selecting effective antisense oligonucleotide sequences and effective antisense target sequences are provided, as are sequences selected according to these methods. In other methods of the invention, oligonucleotides are designed to hybridize to target sequences containing one or more activity-enhancing motifs. Antisense oligonucleotides designed according to these methods are also provided.
    Type: Application
    Filed: September 10, 2009
    Publication date: May 6, 2010
    Inventors: Susan M. Freier, Olga Matveeva, Alexander Tsodikov, Michael C. Giddings, Jacqueline R. Wyatt
  • Patent number: 7592440
    Abstract: Methods for obtaining antisense oligonucleotides with activity against a desired target are provided. Methods of identifying oligonucleotide sequence motifs which are predictive of antisense oligonucleotide activity are provided, as are motifs identified according to this method. Methods of selecting effective antisense oligonucleotide sequences and effective antisense target sequences are provided, as are sequences selected according to these methods. In other methods of the invention, oligonucleotides are designed to hybridize to target sequences containing one or more activity-enhancing motifs. Antisense oligonucleotides designed according to these methods are also provided.
    Type: Grant
    Filed: October 15, 2003
    Date of Patent: September 22, 2009
    Assignees: Isis Pharmaceuticals, Inc., University of Utah
    Inventors: Susan M. Freier, Olga Matveeva, Alexander Tsodikov, Michael C. Giddings, Jacqueline R. Wyatt
  • Publication number: 20040115716
    Abstract: Methods for obtaining antisense oligonucleotides with activity against a desired target are provided. Methods of identifying oligonucleotide sequence motifs which are predictive of antisense oligonucleotide activity are provided, as are motifs identified according to this method. Methods of selecting effective antisense oligonucleotide sequences and effective antisense target sequences are provided, as are sequences selected according to these methods. In other methods of the invention, oligonucleotides are designed to hybridize to target sequences containing one or more activity-enhancing motifs. Antisense oligonucleotides designed according to these methods are also provided.
    Type: Application
    Filed: October 15, 2003
    Publication date: June 17, 2004
    Inventors: Susan M. Freier, Olga Matveeva, Alexander Tsodikov, Michael C. Giddings, Jacqueline R. Wyatt
  • Publication number: 20040073376
    Abstract: An artificial neural network system for analyzing sequence motif content for prediction of antisense oligonucleotide-target activity is disclosed. The system was developed for high specificity predictions, with cross-validation used to rigorously test against the database that was used in the development of the system. The system is able to choose effective oligonucleotides leading to >75% reduction in RNA target expression with >55% accuracy. This is in contrast to <10% success rate for trial-and-error oligonucleotide selection. Thus, the program provides a five-fold reduction in the number of oligonucleotides to be screened in vivo to find effective targets.
    Type: Application
    Filed: January 14, 2002
    Publication date: April 15, 2004
    Applicant: University of Utah Research Foundation
    Inventors: Raymond F. Gesteland, John F. Atkins, Olga V. Matveeva, Michael C. Giddings